Gabelli Downgrades Lexicon Pharmaceuticals To Hold

By: via Benzinga
Analysts at Gabelli downgraded Lexicon Pharmaceuticals (NASDAQ: LXRX) from Buy to Hold. Lexicon Pharma shares have dropped 27.43% ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.